Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2140523 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
cyclin dependent kinase 2/CDK2/Cyclin A2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038469] [GtoPdb: 1973] [UniProtKB: P20248, P24941] | ||||||||
ChEMBL | Inhibition of full length CDK2/Cyclin A (unknown origin) using 5FAMQSPKKG-CONH2 as substrate after 60 mins by fluorescence assay | B | 4.44 | pIC50 | 36000 | nM | IC50 | J Med Chem (2013) 56: 10045-10065 [PMID:24256217] |
TTK protein kinase/Dual specificity protein kinase TTK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3983] [GtoPdb: 2264] [UniProtKB: P33981] | ||||||||
ChEMBL | Inhibition of human full-length N-terminal GST-tagged MPS1 using FITC-labeled peptide as substrate incubated for 1 hr by Fluorescence based analysis | B | 4.46 | pIC50 | 35000 | nM | IC50 | J Med Chem (2016) 59: 9305-9320 [PMID:27559828] |
ChEMBL | Inhibition of Myc-tagged wild type MPS1 autophosphorylation in human HCT116 cells after 2 hrs in presence of proteosome inhibitor MG132 | B | 6.14 | pIC50 | 720 | nM | IC50 | J Med Chem (2013) 56: 10045-10065 [PMID:24256217] |
ChEMBL | Displacement of tracer K9 from NanoLuc-fused MPS1 (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay | B | 6.37 | pIC50 | 429 | nM | IC50 | J Med Chem (2022) 65: 3173-3192 [PMID:35167750] |
ChEMBL | Inhibition of N-terminal GST-tagged full-length human Mps1 expressed in insect cells using FITC-DHTGFLTEYVATR-CONH2 as substrate after 25 mins by fluorescence assay | B | 7.46 | pIC50 | 35 | nM | IC50 | Eur J Med Chem (2019) 175: 247-268 [PMID:31121430] |
ChEMBL | Inhibition of Mps1 (unknown origin) pretreated for 10 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-glo kinase assay | B | 7.46 | pIC50 | 35 | nM | IC50 | Eur J Med Chem (2023) 253: 115334-115334 [PMID:37037136] |
ChEMBL | Inhibition of GST-fused full length human TTK compound pre-incubated for 15 mins prior ATP addition by MBP-based assay | B | 7.46 | pIC50 | 35 | nM | IC50 | Bioorg Med Chem (2014) 22: 4968-4997 [PMID:25043312] |
ChEMBL | Inhibition of human His-tagged TTK (510 to 857)-mediated MBP phosphorylation after 20 mins by scintillation counting analysis in presence of gamma-[32P]ATP | B | 7.46 | pIC50 | 35 | nM | IC50 | J Med Chem (2015) 58: 3366-3392 [PMID:25763473] |
GtoPdb | In vitro assay using a His-tagged catalytic domain fragment of MPS1 (amino acids 510–857). | - | 7.46 | pIC50 | ~35 | nM | IC50 | J Cell Biol (2010) 190: 25-34 [PMID:20624899] |
ChEMBL | Inhibition of recombinant human full length N-terminal GST-fused MPS1 (1 to 857 residues) using histone H3 as substrate by TR-FRET assay | B | 8.01 | pIC50 | 9.79 | nM | IC50 | J Med Chem (2022) 65: 3173-3192 [PMID:35167750] |
ChEMBL | Inhibition of N-terminal 6XHis-tagged/GST-tagged full length human MPS1 expressed in recombinant baculovirus infected sf9 insect cells using 5FAM-DHTGFLTEYVATRCONH2 as substrate after 60 to 90 mins by fluorescence assay | B | 8.15 | pIC50 | 7 | nM | IC50 | J Med Chem (2013) 56: 10045-10065 [PMID:24256217] |
aurora kinase A/Serine/threonine-protein kinase Aurora-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
ChEMBL | Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay | B | 4.68 | pIC50 | 21000 | nM | IC50 | J Med Chem (2013) 56: 10045-10065 [PMID:24256217] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]